Blind World Magazine

India and Israel to work together on eye care.

November 21, 2005.

India and Israel should work together to fight the increasing ophthalmic problems and there is an urgent need for like-minded institutions to work in that direction, Ravi Thomas, director, LV Prasad Eye Institute, has said.

Speaking during the inauguration of the Indo-Israel Ophthalmic Congress, Ravi said that by developing a common platform, India could take leadership in ophthalmic developments. He said infrastructure building in rural areas had its own limitations. The advent of telemedicine has thrown open many opportunities.

Gullapalli N Rao, president, L V Prasad Eye Institute, Hyderabad, speaking on the occasion, said, 'if all these institutes are put together then we will be able to come to the level of any developed country in eye-care'. He added, 'there is an urgent need to develop infrastructure facilities like satellite centres to address growing eye-related problems'. Pointing out that of the 1.4 billion population, almost 1.5 million were visually challenged, he said the three most common diseases causing visual impairment in India were cataract, retinal diseases and glaucoma. M P Namperumalsamy, director, Aravind Eye Hospitals, Madurai, said, 'we must try to exploit the benefits of Information Technology in addressing these problems'.

Chennai-based Sankara Nethralaya has taken the initiative to bring four other institutions in the country like Aravind Eye hospital, L V Prasad Eye Institute, Shri Ganapati Netralaya and Shri Sankaradeva Nethralaya to organise the two-day Indo-Israel Ophthalmic Congress. Twelve leading ophthalmologists from Israel were present during the inauguration.

End of article.

Any further reproduction or distribution of this article in a format other than a specialized format, may be an infringement of copyright.

Go to ...

Top of Page.

Previous Page.

List of Categories.

Home Page.

Blind World Website
Designed and Maintained by:
George Cassell
All Rights Reserved.

Copyright Notice
and Disclaimer.